Stifel Financial Corp Has $3.22 Million Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Stifel Financial Corp boosted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 14.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 151,589 shares of the company’s stock after buying an additional 18,952 shares during the quarter. Stifel Financial Corp owned approximately 0.06% of Oscar Health worth $3,215,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Raymond James & Associates bought a new position in shares of Oscar Health in the second quarter valued at about $3,168,000. Hennessy Advisors Inc. bought a new position in Oscar Health in the 2nd quarter valued at about $9,047,000. Catalyst Capital Advisors LLC acquired a new stake in Oscar Health during the second quarter worth approximately $1,535,000. Bank of New York Mellon Corp boosted its holdings in shares of Oscar Health by 161.4% during the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock worth $22,038,000 after acquiring an additional 860,226 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Oscar Health by 26.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company’s stock valued at $383,000 after purchasing an additional 5,138 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 6,516 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the transaction, the insider now owns 81,962 shares of the company’s stock, valued at $1,481,872.96. This represents a 7.36 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at approximately $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Jefferies Financial Group began coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Piper Sandler restated an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Finally, UBS Group started coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Oscar Health has a consensus rating of “Hold” and a consensus price target of $21.56.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $13.50 on Wednesday. The firm has a 50 day moving average of $16.14 and a 200-day moving average of $17.51. Oscar Health, Inc. has a 12 month low of $7.67 and a 12 month high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $3.34 billion, a PE ratio of -224.96 and a beta of 1.63.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.29) earnings per share. On average, equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.